Logo

GVK Biosciences Expands Distributor List in Asia

Mar 01, 2013
Premium

GVK Biosciences said this week that it has tapped Genesis Genetics Asia to distribute its informatics database products and services to pharmaceutical and biotechnology companies in Taiwan.

Sreeni Devidas, GVK Bio's vice president of business development and informatics, said in a statement that GGA would distribute its structure activity relation, biomarker, and clinical outcomes databases and also promote its information technology and data curation services.

GVK Bio's customer base includes the US Food and Drug Administration, which recently renewed its license to the company's clinical biomarker database (BI 1/18/2013).

Filed under

Informatics
GVK Biosciences
Breaking News
The Scan

Positive Framing of Genetic Studies Can Spark Mistrust Among Underrepresented Groups

Researchers in Human Genetics and Genomics Advances report that how researchers describe genomic studies may alienate potential participants.

Small Study of Gene Editing to Treat Sickle Cell Disease

In a Novartis-sponsored study in the New England Journal of Medicine, researchers found that a CRISPR-Cas9-based treatment targeting promoters of genes encoding fetal hemoglobin could reduce disease symptoms.

Gut Microbiome Changes Appear in Infants Before They Develop Eczema, Study Finds

Researchers report in mSystems that infants experienced an enrichment in Clostridium sensu stricto 1 and Finegoldia and a depletion of Bacteroides before developing eczema.

Acute Myeloid Leukemia Treatment Specificity Enhanced With Stem Cell Editing

A study in Nature suggests epitope editing in donor stem cells prior to bone marrow transplants can stave off toxicity when targeting acute myeloid leukemia with immunotherapy.